SEC Company Response from Theriva Biologics, Inc. (TOVX) (CIK 0000894158) (TOVX) — Oct 14, 2015
Theriva Biologics, Inc. (TOVX) (CIK 0000894158)
Date: Oct. 14, 2015 · CIK: 0000894158 · Accession: 0001144204-15-059348
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-207327
Letter
VIA EDGAR United States Securities Attention: Suzanne Hayes, Assistant Director Registration Statement on Form S-3 Filed October 7, 2015 File No. 333-207327
Re: Synthetic Biologics, Inc.
Dear Ms. Hayes:
Synthetic Biologics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it may become effective by 5:00 p.m. Eastern Daylight Time on October 15, 2015 or as soon thereafter as reasonably practicable.
In making this request, the Company acknowledges that: (i) should the Securities and Exchange Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it will not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
SYNTHETIC BIOLOGICS, INC.
By: /s/ Steven A. Shallcross
Steven A. Shallcross, Chief Financial Officer
Show Raw Text
CORRESP
1
filename1.htm
October 14, 2015
VIA EDGAR
United States Securities
and
Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Suzanne Hayes, Assistant Director
Re: Synthetic Biologics, Inc.
Registration Statement
on Form S-3
Filed October 7, 2015
File No. 333-207327
Dear Ms. Hayes:
Synthetic Biologics,
Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it may become effective by 5:00 p.m. Eastern Daylight Time on October 15, 2015 or as soon thereafter as reasonably practicable.
In making this request,
the Company acknowledges that: (i) should the Securities and Exchange Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it will not foreclose the Commission from taking any action with respect to the filing; (ii) the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve
the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may
not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.
SYNTHETIC BIOLOGICS, INC.
By:
/s/ Steven A. Shallcross
Steven A. Shallcross, Chief Financial Officer